BAFTA- AT (Version 1)
Research type
Research Study
Full title
Exploring barriers and facilitators to treatment adherence in adolescents engaged in anticoagulant therapy: a qualitative study.
IRAS ID
218785
Contact name
Kay Rooney
Contact email
Sponsor organisation
The Newcastle upon Tyne Hospitals NHS Foundation Trust
Duration of Study in the UK
0 years, 11 months, 24 days
Research summary
This study will explore the barriers (mechanisms that make adherence less likely) and facilitators (mechanisms that support greater adherence) to treatment adherence in adolescents (10-19 years of age) engaged in anticoagulant therapy (blood thinning treatment). The term adherence relates to the extent to which the patient acts consistently in accordance with medical recommendations; medication, medical advice, lifestyle changes and other such adaptive adjustments. The definition of an adolescent is in line with the World Health Organisation classification of an adolescent as aged between 10 and 19 years of age. Anticoagulant therapy (AT) is a drug treatment administered to individuals at risk of thrombosis to thin their blood. It is reported that adolescents present a challenge to the maintenance of treatment stability due to non-adherence; which elevates the risk of complications associated with AT. At current, there is a developing evidence base for adherence to AT in adults, though few studies have explored adherence specifically in adolescents. The value of exploring both barriers (mechanisms that make adherence less likely) and facilitators (mechanisms that support greater adherence) enables an enhanced understanding of behavioural enactment (or not) and allows for the collection of key evidence to support the development of tailored interventions, to improve health outcomes and service provisions for adolescents engaged in AT.
REC name
South Central - Oxford C Research Ethics Committee
REC reference
17/SC/0270
Date of REC Opinion
26 May 2017
REC opinion
Favourable Opinion